Abigail I. Guce, Ph.D. - Publications
Affiliations: | 2010 | University of Massachusetts, Amherst, Amherst, MA |
Area:
Biochemistry, Pharmaceutical ChemistryYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Ryan KC, Guce AI, Johnson OE, Brunold TC, Cabelli DE, Garman SC, Maroney MJ. Nickel superoxide dismutase: structural and functional roles of His1 and its H-bonding network. Biochemistry. 54: 1016-27. PMID 25580509 DOI: 10.1021/Bi501258U | 0.592 | |||
2013 | Garman S, Guce AI, Clark NE, Rogich JJ. The molecular basis of pharmacological chaperoning in human alpha-galactosidase Molecular Genetics and Metabolism. 108: S41-S42. DOI: 10.1016/J.Ymgme.2012.11.091 | 0.685 | |||
2011 | Guce AI, Clark NE, Rogich JJ, Garman SC. The molecular basis of pharmacological chaperoning in human α-galactosidase. Chemistry & Biology. 18: 1521-6. PMID 22195554 DOI: 10.1016/J.Chembiol.2011.10.012 | 0.656 | |||
2010 | Tomasic IB, Metcalf MC, Guce AI, Clark NE, Garman SC. Interconversion of the specificities of human lysosomal enzymes associated with Fabry and Schindler diseases. The Journal of Biological Chemistry. 285: 21560-6. PMID 20444686 DOI: 10.1074/Jbc.M110.118588 | 0.699 | |||
2010 | Guce AI, Clark NE, Salgado EN, Ivanen DR, Kulminskaya AA, Brumer H, Garman SC. Catalytic mechanism of human alpha-galactosidase. The Journal of Biological Chemistry. 285: 3625-32. PMID 19940122 DOI: 10.1074/Jbc.M109.060145 | 0.71 | |||
2010 | Guce AI, Garman SC. The structure of human α-galactosidase a and implications for fabry disease Fabry Disease. 21-38. DOI: 10.1007/978-90-481-9033-1_2 | 0.647 | |||
2009 | Herbst RW, Guce A, Bryngelson PA, Higgins KA, Ryan KC, Cabelli DE, Garman SC, Maroney MJ. Role of conserved tyrosine residues in NiSOD catalysis: a case of convergent evolution. Biochemistry. 48: 3354-69. PMID 19183068 DOI: 10.1021/Bi802029T | 0.625 | |||
Show low-probability matches. |